Delivering Personalised Healthcare
We are committed to the future of healthcare, which we see as a blend of precision medicine and cutting-edge digital technologies. Our mission is to harness these advancements to enhance the health and well-being of our patients, ensuring that each individual receives care tailored to their unique genetic makeup and health needs.
The team
Saad Rudda
Clinical & SI Pharmacist
GPHC Number: 2085892
Timar Misghina
Clinical Prescriber
Gphc number: 2221039
Nimesh Vensia
Independent Prescriber
Gphc number: 2086824
Abdullah Sabyah
Chairman & CEO
WDA(h) Responsible Person
Mr Anas Abuyazid
Non Executive Director
Corporate Governance
Prof Sir John Cunningham
Non Executive Director
Science Advisor & NED
Our story
2017
The Foundation
The journey of Rightangled began with a personal health crisis that struck close to home for co-founder Floriane. A family member, prescribed Plavix (Clopidogrel) for post-stroke recovery, faced severe side effects like gum bleeding and bruising. These complications, coupled with the medication's apparent ineffectiveness, starkly highlighted the necessity for a more personalised approach to treatment. Motivated by this experience, Floriane & Abdullah set out to change how medical treatments are prescribed.
2018
NHS Funding
With Abdullah's knowledge about genetics and it's influence on the way people respond to drugs, he and Flo set out to make genetic information more accessible. This led to the development of a new service that integrates genetic insights into medical practice. The project later received the approval and funding from NHS England, through one of it's innovation adoption arms (the West Midlands Academic Health Science Network). What started as a push to improve healthcare for a family member has turned into the Rightangled's goal to shake up the traditional healthcare system.
2020
Innovation and Expansion
Over the next 4 years, Rightangled focused on developing innovative home testing technologies that could inform more accurate and individualised treatment plans. The company grew rapidly, establishing itself as a leader in home-based healthcare solutions, expanding their services to cater to a broader range of medical conditions and patient needs.
2023
A New Chapter
In 2023, Rightangled entered a transformative phase, becoming part of the Sibie Group. This new alliance enabled Rightangled to partner with Wegoss Online Pharmacy, one of Sibie’s subsidiary companies. Together, they began to dispense prescriptions directly to patients, streamlining the process from genetic testing to treatment delivery. This partnership marked a significant milestone, enhancing the integration of personalised medicine into everyday healthcare.
Our Partners